Uso de la Cabergolina en Obstetricia y Ginecología
Use of Cabergoline in Obstetrics and Ginecology
Resumen
Bibliografía
1. Chen H, Fu J, Huang W. Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history. Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.: CD008883. DOI: 10.1002/14651858.CD008883.pub2. Disponible en: https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD008883.pub2/epdf/full [Acceso 20/05/2022]
2. Mourad S, Brown J, Farquhar C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2017, Issue 1. Art. No.: CD012103. DOI: 10.1002/14651858.CD012103.pub2.. Dis-ponible en: https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD012103.pub2/epdf/full [Acceso 20/05/2022].
3. Tang H, Mourad SM., Wang A, Zhai S-D, Hart RJ. Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2021, Issue 4. Art. No.: CD008605. DOI: 10.1002/14651858.CD008605.pub4. Dis-ponible en: https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD008605.pub4/epdf/full [Acceso 20/05/2022].
4. American Society for Reproductive Medicine. Medicamentos Para Inducir La Ovulación. Guía para pacientes. Medline; 2012. Disponible en:
https://www.reproductivefacts.org/globalassets/rf/news-and-publications/bookletsfact-sheets/spanish-fact-sheets-and-info-booklets/medicamentos_para_inducir_la_ovulacion-spanish.pdf [Acceso 20/05/2022].
5. Llupià A., Torà I., Lladó A., Cobo T., Sotocaa J. M., Puig J. Factors related to inhibition of lactation by pharmacological means at birth in a Spanish referral hospital (2011-2017). Gaceta Sanitaria. (2022);36(1):6–11. Disponible en:
Factors related to inhibition of lactation by pharmacological means at birth in a Spanish referral hospital (2011-2017) (isciii.es) [Acceso 20/05/2022].
6. Rincón García A.G., Chacín de Rincón B., Borja A. M. Inhibicion de la lactancia con cabergolina. Efectos sobre los síntomas y sobre el nivel de prolactina. Universidad de los Andes (Venezuela); 2017. Disponible en:
Microsoft Word - cabergol version Revista.doc (researchgate.net) [Acceso 20/05/2022].
- Resumen visto - 519 veces
- PDF descargado - 158 veces
